Segall Bryant & Hamill’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,134,813	Closed	-$8.61M	–	580
2025 Q3	$8.61M	Sell	1,134,813 -85,264	-7%	-$710K	0.11%	256
2025 Q2	$10.9M	Sell	1,220,077 -110,237	-8%	-$1.03M	0.15%	214
2025 Q1	$9.98M	Sell	1,330,314 -91,882	-6%	-$741K	0.15%	216
2024 Q4	$10.7M	Sell	1,422,196 -68,180	-5%	-$518K	0.15%	213
2024 Q3	$11.3M	Sell	1,490,376 -36,105	-2%	-$274K	0.15%	206
2024 Q2	$9.43M	Sell	1,526,481 -222,967	-13%	-$1.23M	0.17%	200
2024 Q1	$8.89M	Buy	1,749,448 +10,131	+0.6%	+$57K	0.17%	211
2023 Q4	$10.4M	Sell	1,739,317 -278,669	-14%	-$1.61M	0.2%	180
2023 Q3	$14.3M	Sell	2,017,986 -19,702	-1%	-$142K	0.17%	164
2023 Q2	$14.3M	Buy	2,037,688 +199,834	+11%	+$1.6M	0.15%	180
2023 Q1	$15.3M	Buy	1,837,854 +168,855	+10%	+$1.63M	0.17%	167
2022 Q4	$19.2M	Sell	1,668,999 -12,190	-0.7%	-$152K	0.21%	139
2022 Q3	$21.2M	Sell	1,681,189 -142,020	-8%	-$1.83M	0.25%	116
2022 Q2	$19.3M	Buy	1,823,209 +879,417	+93%	+$9.07M	0.22%	130
2022 Q1	$15.3M	Buy	+943,792	New	+$15.1M	0.15%	166